From: Risk factors for and clinical outcomes of carbapenem non-susceptible gram negative bacilli bacteremia in patients with acute myelogenous leukemia
Variables
aOR (95% CI)
P
Carbapenem use at the onset of GNB bacteremia
91.2 (29.3–284.1)
< 0.001
Isolation of CRAB in the prior 1 year
19.4 (3.4–112.5)
0.001
Days from chemotherapy to GNB bacteremia
1.1 (1.1–1.2)